Comparison 7. Minocycline versus doxycycline.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Number of participants with > 50% reduction in IL count | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
2 Global efficacy rating | 3 | Risk Ratio (M‐H, Fixed, 95% CI) | Subtotals only | |
2.1 Overal efficacy: participant‐assessed | 1 | 64 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.06 [0.89, 1.28] |
2.2 Overal efficacy: investigator‐assessed | 3 | 150 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.99 [0.88, 1.12] |
3 Cure | 1 | 50 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.5 [0.10, 2.49] |
4 Other outcome | Other data | No numeric data |